Infection control in the multidrug-resistant era: tending the human microbiome.
about
The potential impact of coinfection on antimicrobial chemotherapy and drug resistanceThe Gut-Brain Axis: The Missing Link in Depression.Perturbation of the human microbiome as a contributor to inflammatory bowel diseaseAgent Based Modeling of Human Gut Microbiome Interactions and Perturbations.The advantages of second best: comment on "Lactobacilli vs antibiotics to prevent urinary tract infections"Fecal microbiota transplantation for refractory Clostridium difficile colitis in solid organ transplant recipientsGut Health in the era of the human gut microbiota: from metaphor to biovalue.Human pharyngeal microbiome may play a protective role in respiratory tract infections.Dangerous Ideas: resistant superbugs and the potential of the microbiome.Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection.Has the emergence of community-associated methicillin-resistant Staphylococcus aureus increased trimethoprim-sulfamethoxazole use and resistance?: a 10-year time series analysis.Causes, consequences, and perspectives in the variations of intestinal density of colonization of multidrug-resistant enterobacteria.The human microbiota: novel targets for hospital-acquired infections and antibiotic resistance.Postinfectious functional gastrointestinal disorders: a focus on epidemiology and research agendas.Relative fecal abundance of extended-spectrum-β-lactamase-producing Escherichia coli strains and their occurrence in urinary tract infections in women.Oral DAV131, a charcoal-based adsorbent, inhibits intestinal colonization by β-lactam-resistant Klebsiella pneumoniae in cefotaxime-treated miceClearance of Vancomycin-Resistant Enterococcus Concomitant With Administration of a Microbiota-Based Drug Targeted at Recurrent Clostridium difficile InfectionThe natural killer cell interferon-gamma response to bacteria is diminished in untreated HIV-1 infection and defects persist despite viral suppressionThe chronic gastrointestinal consequences associated with campylobacter.Detection and clinical relevance of Staphylococcus aureus nasal carriage: an update.Epidemiology and prevention of carbapenem-resistant Enterobacteriaceae in the United States.The potential role of microbiota for controlling the spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) in neonatal population.Multidrug-resistant bacteria in hematology patients: emerging threats.Gastrointestinal Carriage Is a Major Reservoir of Klebsiella pneumoniae Infection in Intensive Care Patients.Can Consideration of the Microbiome Improve Antimicrobial Utilization and Treatment Outcomes in the Oncology Patient?Contact precautions for preventing nosocomial transmission of ESBL-producing Escherichia coli - a point/counterpoint review.Ethical Issues in Fecal Microbiota Transplantation in Practice.Risk Factors for Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) Acquisition Among Contacts of Newly Diagnosed CP-CRE Patients.Predominance of Lactobacillus spp. Among Patients Who Do Not Acquire Multidrug-Resistant OrganismsBacteriophages to reduce gut carriage of antibiotic resistant uropathogens with low impact on microbiota composition.Immunological Biomarkers in Postinfectious Irritable Bowel Syndrome.Surveillance cultures growing carbapenem-Resistant Acinetobacter baumannii predict the development of clinical infections: a retrospective cohort study.The gut is the epicentre of antibiotic resistance.Microbiota Replacement Therapies: Innovation in Gastrointestinal Care.Editorial Commentary: The Dawning of Microbiome Remediation for Addressing Antibiotic Resistance.Risk of Subsequent Sepsis within 90 Days of a Previous Hospital Stay by Type of Antibiotic Exposure.Help, hope and hype: ethical considerations of human microbiome research and applications.The Human Microbiome and Public Health: Social and Ethical ConsiderationsTherapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis
P2860
Q28081282-C69A9FD7-2929-4613-A479-5CCDB7E8A14CQ34502723-AD0948CD-5815-410E-B266-C1405A638D51Q34569117-21BF08D7-90CB-478E-83AA-F4790D26D2DCQ34675803-C0FA6CC3-E1B2-414D-AE68-2139A91BE5A2Q34850099-07C3C494-D4F9-453B-BC81-E72BDD09DCF8Q35085463-15ECDF54-83E2-4352-8AE3-713770957242Q35115051-2F1C7801-47B9-45E5-831C-2AFDE4112201Q35192938-7315DE8C-95F6-4887-9788-FA45413F7E6BQ35469137-388F150F-5095-4A5E-A9BE-809012E3228AQ35605686-944B6330-8CB2-42A5-8950-305B7B7BB39EQ36364141-9B1EDD70-0871-476B-B18E-B66A18EC3947Q36878269-33CA2859-A3C3-4780-B0C2-316C08217B75Q36968334-DE605BD4-7F6D-4E6E-9E03-B86DCD17BD9FQ37099359-B72BEE66-0CF0-4990-95B0-A7D6FE526805Q37124242-D6544244-45EB-4B37-9A42-D2958513DD91Q37263410-C78FA862-21A4-44E8-B4BC-0F5E06A7453CQ37305507-ECB54AAE-6F7B-42C2-87DD-2E00DF4B705EQ37622761-E7F647D5-CA37-4110-80F7-5164CCED80AEQ38032174-C6B697FF-60C8-4F72-A52D-2A8DFDC1617CQ38168927-E04731F4-D51F-40C7-8603-E4E57C169263Q38199187-0B2435B7-B326-4A2D-BC36-4469412041ACQ38637932-3119A7FE-0B59-4E56-9DB5-110BED9DEDCFQ38838498-E6B7B755-A4D5-441F-A789-C5A4017F0F43Q38860335-1CA0A6E2-6289-4BB9-AF3F-E926B952D76EQ39180730-5781A631-1121-4238-A9D2-D3B73C688E9BQ39221599-4F401BAA-49D1-470C-817E-F1EDD16B892DQ40242658-D5D6FA03-320B-4024-ADFD-17A4AFF9F54AQ40601745-99078A65-2946-4D85-8E26-5433C41071BEQ40631019-D095798C-191B-4BEA-8506-79F5AAE7ADE7Q40757720-759A8A15-42F8-4E61-B51B-1B745FC23F08Q41172853-9284E018-A224-4A0F-AF51-863F169997F2Q41685804-D0B59A0E-C228-4BBA-A4BC-D43D67E3C709Q42116425-585C8608-D206-4347-B92C-9A00A9254BBDQ46274429-1831AADD-F4BD-4CC9-BE5B-070A1277DE10Q46572123-99C02168-0FE2-43DC-AE71-CE4065600D93Q47599691-E963E732-AC5B-4387-87EB-F2F748F6EF99Q54969645-631299BA-42CD-4884-9C46-E7FB1DF6EF60Q58659933-A86F0826-2F2F-401F-A865-2926372A4797Q58754447-CE93E7CB-A241-4FB7-8C5A-FA8B516FD577
P2860
Infection control in the multidrug-resistant era: tending the human microbiome.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Infection control in the multidrug-resistant era: tending the human microbiome.
@en
Infection control in the multidrug-resistant era: tending the human microbiome.
@nl
type
label
Infection control in the multidrug-resistant era: tending the human microbiome.
@en
Infection control in the multidrug-resistant era: tending the human microbiome.
@nl
prefLabel
Infection control in the multidrug-resistant era: tending the human microbiome.
@en
Infection control in the multidrug-resistant era: tending the human microbiome.
@nl
P2860
P356
P1476
Infection control in the multidrug-resistant era: tending the human microbiome.
@en
P2093
L Clifford McDonald
Pritish K Tosh
P2860
P304
P356
10.1093/CID/CIR899
P407
P577
2011-12-12T00:00:00Z